A large U.S. cohort study found that antibiotics were not associated with improved outcomes for patients hospitalized with non-severe COVID-19. Further analyses, including a propensity-matched ...

Early antibiotic treatment in patients with nonsevere COVID-19 showed no significant clinical benefit and may worsen outcomes. High antibiotic use during the pandemic contrasts with low bacterial ...

Although a number of studies have found that a diabetes drug called metformin reduces the risk of long COVID, new research finds that it does not reduce symptoms of the condition.

About The Study: In this large cohort study of patients hospitalized with nonsevere COVID-19, there was no clinically meaningful difference in outcomes with early antibiotic treatment. Given the risks ...

Background and Goal: The COVID-19 pandemic and lockdown measures in France affected health care access and prescribing patterns, leading to significant changes in outpatient (ambulatory) antibiotic ...

Antimalaria drugs that U.S. President Donald Trump has touted for treatment of Covid-19 were linked to an increased risk of death and heart ailments in a study. Hydroxychloroquine and chloroquine didn ...

The guidance aims to help accelerate the development of new antibiotics for severe, drug-resistant gram-negative and gram-positive infections and community-acquired and healthcare-associated bacterial ...

DEAR DR. ROACH: What is the difference between antibiotics and antivirals? -- A.T.G. ANSWER: Antibiotics are an effective treatment for bacteria. Some antibiotics are very broad, meaning that they can ...

The odor and discharge are strongly suggestive of a bacterial sinus infection. COVID infections, like all viral infections, ...